286 related articles for article (PubMed ID: 22957695)
1. Antitumor platinum(II) complexes containing platinum-based moieties of present platinum drugs and furoxan groups as nitric oxide donors: synthesis, DNA interaction, and cytotoxicity.
Zhao J; Gou S; Sun Y; Fang L; Wang Z
Inorg Chem; 2012 Oct; 51(19):10317-24. PubMed ID: 22957695
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
Coley HM; Sarju J; Wagner G
J Med Chem; 2008 Jan; 51(1):135-41. PubMed ID: 18072719
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, antiproliferative activity and DNA binding study of mixed ammine/cyclohexylamine platinum(II) complexes with 1-(substituted benzyl) azetidine-3, 3-dicarboxylates.
Sun Y; Gou S; Yin R; Jiang P
Eur J Med Chem; 2011 Oct; 46(10):5146-53. PubMed ID: 21875765
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, cytotoxicity and DNA-binding levels of ammine/propylamine platinum(II) complexes with carboxylates.
Zhang J; Zhao X
Eur J Med Chem; 2007 Feb; 42(2):286-91. PubMed ID: 17084487
[TBL] [Abstract][Full Text] [Related]
5. Novel nitric oxide-releasing derivatives of farnesylthiosalicylic acid: synthesis and evaluation of antihepatocellular carcinoma activity.
Ling Y; Ye X; Zhang Z; Zhang Y; Lai Y; Ji H; Peng S; Tian J
J Med Chem; 2011 May; 54(9):3251-9. PubMed ID: 21504204
[TBL] [Abstract][Full Text] [Related]
6. trans-Dichloridopalladium(II) and platinum(II) complexes with 2-(hydroxymethyl)pyridine and 2-(2-hydroxyethyl)pyridine: synthesis, structural characterization, DNA binding and in vitro cytotoxicity studies.
Icsel C; Yilmaz VT; Ari F; Ulukaya E; Harrison WT
Eur J Med Chem; 2013 Feb; 60():386-94. PubMed ID: 23314052
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, in vitro cytotoxicity, and interaction with DNA of platinum(II) complexes with N-monocycloalkyl derivatives of 1R,2R-diaminocyclohexane as carrier ligands.
Sun Y; Gou S; Liu F; Yin R; Fang L
ChemMedChem; 2012 Apr; 7(4):642-9. PubMed ID: 22247027
[TBL] [Abstract][Full Text] [Related]
8. Antitumor platinum(II) complexes of N-monoalkyl 1R,2R-diamino-cyclohexanes with 3-(nitrooxy)cyclobutane-1,1-dicarboxylate as a leaving group.
Zhao J; Gou S; Xu G; Cheng L
Eur J Med Chem; 2014 Oct; 85():408-17. PubMed ID: 25108080
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, cytotoxicity and DNA-binding levels of new type binuclear platinum(II) complexes.
Zhang J; Li Y; Sun J; Li W; Gong Y; Zheng X; Cui J; Wang R; Wu J
Eur J Med Chem; 2009 Nov; 44(11):4772-7. PubMed ID: 19615790
[TBL] [Abstract][Full Text] [Related]
10. [Synthesis and antitumor activities of triazacyclodecane and its platinum (II) complex].
Zhou SS; Zhang QY; Qin K; Lu CH; Xie FX
Yao Xue Xue Bao; 2008 May; 43(5):490-4. PubMed ID: 18717336
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization and antitumor activity of new type binuclear platinum(II) complexes.
Zhang J; Liu L; Gong Y; Zheng X; Yang M; Cui J; Shen S
Eur J Med Chem; 2009 May; 44(5):2322-7. PubMed ID: 18524422
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization and cytotoxicity of iodo-bridged binuclear platinum(II) complexes.
Zhang J; Li L; Ji X; Sun J; Wang L; Zhang Y
Eur J Med Chem; 2010 Jun; 45(6):2634-7. PubMed ID: 20153562
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization and cytotoxicity of ammine/ethylamine platinum(II) complexes with carboxylates.
Zhang J; Li Y; Sun J
Eur J Med Chem; 2009 Jun; 44(6):2758-62. PubMed ID: 19056150
[TBL] [Abstract][Full Text] [Related]
14. Platinum(II) complexes with l-methionylglycine and l-methionyl-l-leucine ligands: synthesis, characterization and in vitro antitumoral activity.
Kaluderović GN; Schmidt H; Paschke R; Kalinowski B; Dietrich A; Mueller T; Steinborn D
J Inorg Biochem; 2007 Mar; 101(3):543-9. PubMed ID: 17223197
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, cytotoxicity, induction of apoptosis, and interaction with DNA of dinuclear platinum(II) complexes.
Xu G; Gao C; Gou S; Cao Z
ChemMedChem; 2012 Nov; 7(11):2004-9. PubMed ID: 23015351
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and cytotoxicity of enantiomerically pure [1,2-diamino-1-(4-fluorophenyl)-3-methylbutane]platinum(II) complexes.
Dullin A; Dufrasne F; Gelbcke M; Gust R
ChemMedChem; 2006 Jun; 1(6):644-53. PubMed ID: 16892405
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, characterisation and chemical reactivity of mixed-ligand platinum(II) oxadiazoline complexes with potential cytotoxic properties.
Wagner G; Marchant A; Sayer J
Dalton Trans; 2010 Sep; 39(33):7747-59. PubMed ID: 20657943
[TBL] [Abstract][Full Text] [Related]
19. Platinum (II) complexes with stereochemically-defined thiepane dioxide diamine ligands as anticancer drugs.
Cerè V; Grossi L; Munari D; Pollicino S; Martelli L; Martelli M
Anticancer Res; 2006; 26(3A):1815-9. PubMed ID: 16827112
[TBL] [Abstract][Full Text] [Related]
20. Heterometallic platinum(II) compounds with β-aminoethylferrocenes: synthesis, electrochemical behaviour and anticancer activity.
Nieto D; González-Vadillo AM; Bruña S; Pastor CJ; Ríos-Luci C; León LG; Padrón JM; Navarro-Ranninger C; Cuadrado I
Dalton Trans; 2012 Jan; 41(2):432-41. PubMed ID: 22025199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
